Health Care Counsel Blog
856 total results. Page 14 of 35.
In a move with far reaching implications for the health care industry, the Department of Health and Human Services (HHS) recently released a proposed rule that would codify into regulation specific requirements that it and its related agencies must follow when issuing guidance to the public or regul
Headlines that Matter for Companies and Executives in Regulated Industries
Headlines that Matter for Companies and Executives in Regulated Industries
CMS is soliciting comments on whether future payments for devices that may have been impacted by the COVID-19 PHE should be adjusted.
Due to the broader spread of COVID-19 in California, the Department of Consumer Affairs (DCA) has extended numerous professional licensing waivers to facilitate the delivery of patient care during the state of emergency.
On August 17, 2020, the Centers for Medicare and Medicaid Services (CMS) issued a Guidance Memorandum (Guidance) setting forth revised state survey agency priorities as well as providing information regarding the resumption of enforcement activities and resolution of open enforcement cases.
On August 17, 2020, CMS encouraged State Survey Agencies to resume some of their normal enforcement activities.
Headlines that Matter for Companies and Executives in Regulated Industries
After a four-month hold, CMS announced on August 6 that it would resume Medicare Fee-For Service (FFS) medical reviews.
Members of the industry should be on the lookout for proposed rules related to this Order and take advantage of all public comment periods.
Headlines that Matter for Companies and Executives in Regulated Industries
On July 22, 2020, the Centers for Medicare & Medicaid Services (CMS) announced new initiatives designed to protect nursing home residents from the novel coronavirus (COVID-19).
Headlines that Matter for Companies and Executives in Regulated Industries
The White House released three Executive Orders on July 24, 2020 setting forth policies that the Administration believes will “deliver lower prescription drug prices to American patients.”
Headlines that Matter for Companies and Executives in Regulated Industries
For health care providers that are out-of-network with a patient’s insurance, navigating reimbursement is a tactical imperative. The current economic environment makes it more difficult for patients to pay coinsurance, while insurers are increasingly motivated to cut expenses.
Headlines that Matter for Companies and Executives in Regulated Industries
As healthcare providers turn their attention to resuming elective surgeries and procedures, it is important that this entry into the “new normal” be undertaken with care. Health care governing boards have an essential fiduciary oversight role in this process.
Headlines that Matter for Companies and Executives in Regulated Industries
The California Privacy Rights and Enforcement Act (CPRA) has qualified for the November 3, 2020 ballot, according to a recent update by the California Secretary of State’s office.
Headlines that Matter for Companies and Executives in Regulated Industries
Pharmaceutical manufacturers and other stakeholders should submit comments on the Proposed Rule by July 20, 2020.
The FDA has just issued a Guidance on what it considers to be appropriate Current Good Manufacturing Practices (CGMPs) for Responding to COVID-19 infections in employees in drug and biological manufacturing facilities.
On June 15, 2020, the owner of several information technology companies was charged in a criminal complaint with bank fraud and for making false statements to a financial institution.
FDA’s website allows you to determine if a particular COVID-19 test has been reviewed by the FDA.